Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].

Journal

The Lancet regional health. Europe
ISSN: 2666-7762
Titre abrégé: Lancet Reg Health Eur
Pays: England
ID NLM: 101777707

Informations de publication

Date de publication:
Oct 2024
Historique:
medline: 23 9 2024
pubmed: 23 9 2024
entrez: 23 9 2024
Statut: epublish

Résumé

[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.].

Identifiants

DOI: 10.1016/j.lanepe.2024.101073 PMID: 39308777 PMC: PMC11415942
pubmed: 39308777
doi: 10.1016/j.lanepe.2024.101073
pii: S2666-7762(24)00240-0
pmc: PMC11415942
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

101073

Commentaires et corrections

Type : ErratumFor

Informations de copyright

© 2024 Published by Elsevier Ltd.

Auteurs

David Hodgson (D)

Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Neil Wilkins (N)

UK Health Security Agency, London, UK.

Edwin van Leeuwen (E)

Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
UK Health Security Agency, London, UK.

Conall H Watson (CH)

UK Health Security Agency, London, UK.

Jonathan Crofts (J)

UK Health Security Agency, London, UK.

Stefan Flasche (S)

Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Mark Jit (M)

Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Katherine E Atkins (KE)

Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, UK.

Classifications MeSH